Pfizer has received approval from Chinese authorities to market its obesity treatment drug, ecnoglutide, for overweight or obese adults. This move comes as generic versions of the drug are expected to hit the market soon, increasing competition in a rapidly growing market.
Source: https://www.bloomberg.com/news/articles/2026-03-06/pfizer-secures-china-nod-for-obesity-drug-as-generics-loom